Highview Capital Management LLC Amgen Inc Transaction History

Highview Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $41,749 - $47,085	-186 Reduced 13.75%	1,167 $263,000
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $3,922 - $4,364	17 Added 1.27%	1,353 $329,000
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $37,056 - $40,994	169 Added 14.48%	1,336 $323,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $232,092 - $265,609	1,167 New	1,167 $263,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highview Capital Management LLC with notifications on news.